Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail?

Sasanka M. Handunnetti; Constantine S. Tam

doi:10.1080/10428194.2020.1811865

Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail?

Sasanka M. Handunnetti, Constantine S. Tam

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	2283-2285
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	61
Issue number	10
DOIs	https://doi.org/10.1080/10428194.2020.1811865
Publication status	Published - 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2020.1811865

Cite this

@article{f477eb314b824931a0b3e9940a020b54,

title = "Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail?",

author = "Handunnetti, {Sasanka M.} and Tam, {Constantine S.}",

note = "Funding Information: For author S. H. Handunnetti: Honoraria from Gilead & Roche; travel expenses from AbbVie; non-financial assistance from Novartis.",

year = "2020",

doi = "10.1080/10428194.2020.1811865",

language = "English",

volume = "61",

pages = "2283--2285",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "10",

}

TY - JOUR

T1 - Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients

T2 - are we closer to a holy grail?

AU - Handunnetti, Sasanka M.

AU - Tam, Constantine S.

N1 - Funding Information: For author S. H. Handunnetti: Honoraria from Gilead & Roche; travel expenses from AbbVie; non-financial assistance from Novartis.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85090462319&partnerID=8YFLogxK

U2 - 10.1080/10428194.2020.1811865

DO - 10.1080/10428194.2020.1811865

M3 - Comment / Debate

C2 - 32900243

AN - SCOPUS:85090462319

SN - 1042-8194

VL - 61

SP - 2283

EP - 2285

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 10

ER -

Immune impacts of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia patients: are we closer to a holy grail?

UN SDGs

Access to Document

Other files and links

Cite this